Skip to main content
All lobbying filings

Marshall & Popp, LLC

Marshall & Popp, LLC filed a Q1 report for Daiichi Sankyo, Inc. on April 17, 2026.

Lobbying for Daiichi Sankyo, Inc. · Biopharmaceutical manufacturer.

As filed: MARSHALL & POPP, LLC for DAIICHI SANKYO, INC.

All filings by Marshall & Popp, LLC · Everything Daiichi Sankyo, Inc. has reported

 Filing · LD-2 quarterly report Q1 report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 17, 2026
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
New Jersey

Official filing document

 Lobbyists on this filing 2
  • HAZEN CLAY MARSHALL
    Previously held: Policy Director-Senate Majority Leader Mitch McConnell; Staff Director, Senate Budget Committee-Senator Don Nickles; Deputy Chief of Staff/Economist, Office of Assistant Majority Leader-Senator Don Nickles; Legislative Assistant-Senator Don Nickles
  • MONICA POPP
    Previously held: Chief of Staff/Deputy Chief of Staff, Office of Senate Republican Whip John Cornyn; Professional Staff Member, U.S. House of Representatives-Energy & Commerce Committee; Legislative Assistant, Senator Jim DeMint

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1

Issues related to prescription drug value, including implementation of the Inflation Reduction Act (PL 117-169), and implementation of Executive Order 14273, Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem